Moonwalk Biosciences, Inc.
Biotechnology
Sponsors visas
Lately:7 news stories in 90 daysFollow changes →
Facts
as of Nov 17, 2026By deeply profiling and targeting the epigenetic code, Moonwalk aims to reprogram cells to their healthy state, fundamentally enabling a new approach to how therapies are discovered and developed.
- Legal name
- Moonwalk Biosciences, Inc.
- Headquarters
- South San Francisco, United States
- Founded
- 2022
- Employees
- 201-500estimated range
- Register numbers
- NAME moonwalk biosciences inc
- Official records
- SEC CIK 2004362
- Website
- moonwalk.bio
These are the key facts about Moonwalk Biosciences, Inc. on Alion as of Nov 17, 2026. Moonwalk Biosciences, Inc. is headquartered in South San Francisco, United States. It was founded in 2022. It has raised $127M in 2 funding rounds. The latest round is Series B of $70M, announced in 2026.
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
What the registers and the postings say about this employer.
Legal entity active
Moonwalk Biosciences, Inc.
Not checked
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Visa
Full chapter →Named in the work visa registers of United States.
United StatesUS 1
#5,756 of 8,997 sponsors
1H-1B filings in 12 months
$123kMedian offered salary
0Open roles in United States
Who they sponsor
The salary offered for each occupationVisa pass · 90 credits In the register as Moonwalk Biosciences, Inc., South San Francisco, CA
Other sponsors in the same field
Alert me
US Department of Labor · latest filing May 20, 2026
Footprint
Hiring in 1 city in 1 country.
1Cities
1Countries
| Site | Type | Open roles | Hires most for | Engineering |
|---|---|---|---|---|
| South San Francisco United States | Headquarters | 0 |
Source: office addresses in postings and company registers
Financials
Funding rounds, investors and revenue on record.
$127MTotal raised
Series BLatest round
2Rounds and grants
Sources: funding announcements, grant and company registers
Milestones
Sep 8
Raised a round Series B $70M · YahooFinance
Jan 5, 2024
Raised a round Series A $57M · Pulse 2.0
2022
Founded
Each milestone is dated by its source: registers, filings, the press
Newsroom
Sep 282026
News · pharmexec.com
Aptar Pharma and Aceso Therapeutics team up to advance an inhaled cystic fibrosis therapy, Moonwalk Biosciences raises a $70 million Series B for its fat-targeted obesity platfor…
Sep 212026
News · RFWrightLSL
On this weeks episode of the Business of Biotech, Alex Aravanis, M.D., Ph.D., CEO of Moonwalk Biosciences, talks about the opportunity in obesity beyond GLP-1s.
Sep 92026
News · YahooFinance
The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today
Sep 82026
News · Pulse 2.0
Moonwalk Biosciences has raised an oversubscribed $70 million Series B financing to advance its pipeline of adipose-targeted RNA interference medicines for obesity and cardiometa…
Sep 82026
News · YahooFinance
SOUTH SAN FRANCISCO & SAN DIEGO, September 08, 2026--Moonwalk Biosciences Announces $70 Million Series B Financing to Advance Adipose-Targeted RNAi Therapies for Obesity and Card…
Apr 22, 20242024
Sources: the outlets named on each headline, each story once
